COST-EFFECTIVENESS OF OXIGEN THERAPY WITH C-PAP FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNOEA SYNDROME (OSA) VERSUS THE STANDARD OF CARE IN THE MEXICAN PUBLIC HEALTH CARE SYSTEM

被引：2
|
作者：
Gay, J. G. [1 ]
Valls, M. [1 ]
Jose Luis, C. [2 ]
机构：
[1] TI Salud, Mexico City, DF, Mexico
[2] INER, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1538
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD89
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of cognitive-behavioural therapy for mental disorders: Implications for public health care funding policy in Canada
    Myhr, Gail
    Payne, Krista
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2006, 51 (10): : 662 - 670
  • [42] Cost-effectiveness analysis of continuous positive airway pressure treatment for obstructive sleep apnea in Singapore from a health system perspective
    Meng, Fanwen
    Ang, Gary Yee
    Chang, Ruth Rui Ying
    Lee, Chuen Peng
    Tan, Kelvin Bryan
    Abisheganaden, John Arputhan
    JOURNAL OF SLEEP RESEARCH, 2025, 34 (02)
  • [43] COST-EFFECTIVENESS STUDY OF COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS TREATMENT IN PUBLIC HEALTH CARE INSTITUTIONS IN MEXICO
    Baca-Muro, V., I
    Soria-Cedillo, I. F.
    Rosas, R.
    Martinez-Revelles, M.
    Olvera, K.
    Garcia-Contreras, F.
    VALUE IN HEALTH, 2009, 12 (03) : A76 - A76
  • [44] Cost-Utility Analysis of Continuous Positive Airway Pressure Therapy Compared With Usual Care for Obstructive Sleep Apnea in the Public Health System in Brazil
    Pachito, Daniela V.
    Eckeli, Alan L.
    Drager, Luciano F.
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 40 : 81 - 88
  • [45] COST-EFFECTIVENESS OF LEVETIRACETAM FOR PATIENTS WITH JUVENILE MYOCLONIC EPILEPSY: A MODELING APPROACH BY THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
    Kayo, M.
    Rosim, R. P.
    Duva, A.
    Ballalai Ferraz, A. F.
    Carmo, E.
    VALUE IN HEALTH, 2017, 20 (09) : A722 - A723
  • [46] Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
    Hu, Sicui
    Yang, Hongxiu
    Chen, Zhihong
    Leng, Xuefei
    Li, Cheng
    Qiao, Lingyan
    Lv, Weiqing
    Li, Tang
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [47] Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China
    Hu, Shaoyan
    Han, Yi
    Zhang, Wenjie
    Zhang, Tianxiang
    Yao, Xingxing
    Liu, Li
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (08) : 742 - 750
  • [48] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS OLANZAPINE, QUETIAPINE AND ZIPRAZIDONE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Nishikawa, A. M.
    Clark, O. A. C.
    Pititto, L.
    VALUE IN HEALTH, 2014, 17 (03) : A217 - A217
  • [49] COST-EFFECTIVENESS ANALYSIS OF ABIRATERONE FOR THE TREATMENT OF ADVANCED PROSTATE CANCER UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Pereira, M. L.
    Bahmdouni, L. S. K.
    Pepe, C.
    Teich, V
    VALUE IN HEALTH, 2012, 15 (07) : A424 - A425
  • [50] A COST-EFFECTIVENESS ANALYSIS OF TELAPREVIR VERSUS BOCEPREVIR IN THE TREATMENT OF HEPATITIS C: A GREEK NATIONAL HEALTH SYSTEM PERSPECTIVE
    Yfantopoulos, J.
    Paparouni, K.
    D'Angelo, E. R.
    VALUE IN HEALTH, 2012, 15 (07) : A394 - A394
12345